Author

A. Corthay

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Tveita· 1 shared B. Gilmour· 1 shared C. Hammarstrom· 1 shared C. W. Wold· 1 shared D. Dzovor· 1 shared E. Dybing· 1 shared E. Hovig· 1 shared I. Oynebraaten· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Tveita

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

RNA-sensing pattern-recognition receptors synergize with TLR2 or dectin-1 to trigger high production of IL-12p70 by human dendritic cells

B. Gilmour, A. Corthay, I. Oynebraten

This study identifies six PRR ligand combinations that induce high IL-12p70 production by human dendritic cells, suggesting potential as adjuvants for cancer vaccines.

bioRxiv · Oct 3, 2022 · PreprintImmunology

Polysaccharides from the fungus Inonotus obliquus activate macrophages into a tumoricidal phenotype via interaction with TLR2, TLR4 and Dectin-1a

C. W. Wold, P. Christopoulos, M. Arias, D. Dzovor, I. Oynebraaten, A. Corthay, K. T. Inngjerdingen

This study shows that acidic polysaccharides from Inonotus obliquus activate macrophages into a tumoricidal phenotype through interactions with TLR2, TLR4, and Dectin-1a.

bioRxiv · Nov 11, 2020 · PreprintImmunology

Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models

J. Waaler, L. Mygland, A. Tveita, M. F. Strand, N. T. Solberg, P. Angell Olsen, K. Lund, S. Alam Brinch, M. Lycke, E. Dybing, V. Nygaard, S. L. Boe, K.-M. Heintz, E. Hovig, C. Hammarstrom, , S. Krauss

This study shows that tankyrase inhibition makes melanoma more responsive to PD-1 checkpoint blockade in mouse models by reducing WNT/β-catenin and YAP signaling.

bioRxiv · Jan 22, 2019Cancer Biology